Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions

Details for Australian Patent Application No. 2002237927 (hide)

Owner Schering Corporation

Inventors Kosoglou, Teddy; Ress, Rudyard, Joseph; Strony, John; Veltri, Enrico, P.

Agent Griffith Hack

Pub. Number AU-B-2002237927

PCT Pub. Number WO2002/058734

Priority 60/264,275 26.01.01 US; 60/324,123 21.09.01 US; 60/264,396 26.01.01 US; 60/264,600 26.01.01 US

Filing date 25 January 2002

Wipo publication date 6 August 2002

Acceptance publication date 21 April 2005

International Classifications

A61K 045/06 Medicinal preparations containing active ingredients not provided for in groups

A61P 009/00 Drugs for disorders of the cardiovascular system

Event Publications

6 February 2003 Application Open to Public Inspection

  Published as AU-B-2002237927

21 April 2005 Application Accepted

  Published as AU-B-2002237927

18 August 2005 Standard Patent Sealed

20 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002237928-METHODS AND COMPOSITIONS FOR EXPRESSING POLYNUCLEOTIDES SPECIFICALLY IN SMOOTH MUSCLE CELLS IN VIVO

2002237926-DELTA SIGMA CONVERTER INCORPORATING A MULTIPLIER